Prevalence and clustering of metabolic risk factors for type 2 diabetes among Chinese adults in Shanghai, China
- Preventing Type 2 Diabetes. Harwell, Todd S.; Dettori, Nancy; Flook, Benjamin N.; Priest, Linda; Williamson, David F.; Helgerson, Steven D.; Gohdes, Dorothy // Diabetes Care;Nov2001, Vol. 24 Issue 11, p2007
Focuses on the results of a survey on the perceptions of Montana residents of the risk and prevention of type 2 diabetes. Subjects; Analyses of the results.
- Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach. Sridhar, G. R.; Nirmala, G.; Apparao, Allam; Madhavi, A. S.; Sreelatha, S.; Rani, J. Sudha; Vijayalakshmi, P. // Lipids in Health & Disease;2005, Vol. 4, p18
Background: Butyrylcholinesterase is an enzyme that may serve as a marker of metabolic syndrome. We (a) measured its level in persons with diabetes mellitus, (b) constructed a family tree of the enzyme using nucleotide sequences downloaded from NCBI. Butyrylcholinesterase was estimated...
- Metabolic Syndrome in Type 2 Diabetes Mellitus in Isfahan, Iran Prevalence and Risk Factors. Mohsen Janghorbani; Masoud Amini // Metabolic Syndrome & Related Disorders;Sep2007, Vol. 5 Issue 3, p243
Background Our goal was to estimate the prevalence and risk factors of metabolic syndrome (MetSyn) in people with type 2 diabetes mellitus (T2DM) using routinely collected data from a clinical information system at Isfahan Endocrinology and Metabolism Research Centre, Iran.Methods Consecutive...
- Testosterone Replacement in Diabetes and the Metabolic Syndrome. // OB/GYN Clinical Alert;Jun2011 Clinical Brief, p12
The article presents a study which determines the effects of testosterone (TST) two percent gel when applied in hypogonadal men with type 2 diabetes (DM2) or metabolic syndrome (MBS) who underwent treatment for one year.
- Testosterone Replacement in Diabetes and the Metabolic Syndrome. Kuritzky, Louis // Neurology Alert;Jun2011 Clinical Brief, p12
The article presents a study conducted by a team led by T. H. Jones and published in the "Diabetes Journal" that explored testosterone (TST) replacement in type 2 diabetes (DM2) and metabolic syndrome (MBS).
- Testosterone Replacement in Diabetes and the Metabolic Syndrome. Jones, T. H. // Internal Medicine Alert;5/29/2011 Supplement, p80
The article focuses on the study conducted by T. H. Jones regarding the effects of testosterone (TST) 2% gel daily applications in hypogonadal men with type 2 diabetes (DM2) and metabolic syndrome (MBS).
- Human resistin and the RELM of Inflammation in diabesity. Al Hannan, Fatima; Culligan, Kevin Gerard // Diabetology & Metabolic Syndrome;2015, Vol. 7 Issue 1, p1
The initial discovery of resistin and resistin-like molecules (RELMs) in rodents suggested a role for these adipocytokines in molecular linkage of obesity, Type 2 Diabetes mellitus and metabolic syndrome. Since then, it became apparent that the story of resistin and RELMs was very much of mice...
- Natural Products for the Treatment of Obesity, Metabolic Syndrome, and Type 2 Diabetes 2014. Thounaojam, Menaka C.; Nammi, Srinivas; Jadeja, Ravirajsinh // Evidence-based Complementary & Alternative Medicine (eCAM);2015, p1
No abstract available.
- The association between periodontal disease and metabolic syndrome among outpatients with diabetes in Jordan. Alhabashneh, Rola; Khader, Yousef; herra, Zaid; Assad, Farah // Journal of Diabetes & Metabolic Disorders;9/30/2015, Vol. 14 Issue 1, p1
Background: To date, conflicting results have been reported about the association between metabolic syndrome (MetS) and periodonttitis. Methods: Two hundred and eighty patients with type 2 diabetes were recruited from outpatients visiting diabetes clinics in Islamic Hospital, Amman-Jordan. The...